User profiles for Pierluigi Navarra
Pierluigi NavarraCatholic University Medical School Verified email at unicatt.it Cited by 9421 |
n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE 2 induced ERK-1 and -2 and HIF-1α induction pathway
…, S Serini, N Maggiano, G Tringali, P Navarra… - …, 2004 - academic.oup.com
n-3 Polyunsaturated fatty acids (PUFAs) inhibit the development of microvessels in mammary
tumors growing in mice. Human colorectal tumors produce vascular endothelial growth …
tumors growing in mice. Human colorectal tumors produce vascular endothelial growth …
The role of small intestinal bacterial overgrowth in Parkinson's disease
…, G Gigante, EC Lauritano, P Navarra… - Movement …, 2013 - Wiley Online Library
Parkinson's disease is associated with gastrointestinal motility abnormalities favoring the
occurrence of local infections. The aim of this study was to investigate whether small intestinal …
occurrence of local infections. The aim of this study was to investigate whether small intestinal …
Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study
Purpose : In laboratory studies electromotive mitomycin C (MMC) demonstrated markedly
increased transport rates compared with passive transport. We performed a prospective study …
increased transport rates compared with passive transport. We performed a prospective study …
Interleukins-1 and -6 Stimulate the Release of Corticotropin-Releasing Hormone-41 from Rat Hypothalamus in Vitro via the Eicosanoid Cyclooxygenase Pathway
P NAVARRA, S TSAGARAKIS, MS FARIA… - …, 1991 - academic.oup.com
It has previously been shown that interleukin-1 (IL-1) directly stimulates the release of CRH-41
from rat hypothalamus in vitro, suggesting that cytokines may mediate the effects of …
from rat hypothalamus in vitro, suggesting that cytokines may mediate the effects of …
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology
Background Migraine is a complex, chronic, painful, neurovascular disorder characterized
by episodic activation of the trigeminal system. Increased levels of calcitonin gene-related …
by episodic activation of the trigeminal system. Increased levels of calcitonin gene-related …
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma
Microglia and macrophages appear to be the most common cells in the GBM microenvironment.
In the present study we investigated the status of macrophages/microglia activation in …
In the present study we investigated the status of macrophages/microglia activation in …
[HTML][HTML] The human microglial HMC3 cell line: where do we stand? A systematic literature review
…, D Mezzogori, F Paciello, G Pozzoli, P Navarra… - Journal of …, 2018 - Springer
Microglia, unique myeloid cells residing in the brain parenchyma, represent the first line of
immune defense within the central nervous system. In addition to their immune functions, …
immune defense within the central nervous system. In addition to their immune functions, …
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation
Neuroinflammation plays a prominent role in the pathophysiology of several neurodegenerative
disorders, including Multiple Sclerosis. Reactive microglial cells are always found in …
disorders, including Multiple Sclerosis. Reactive microglial cells are always found in …
[HTML][HTML] Neovascular age-related macular degeneration: therapeutic management and new-upcoming approaches
Age-related macular degeneration (AMD) constitutes a prevalent, chronic, and progressive
retinal degenerative disease of the macula that affects elderly people and cause central …
retinal degenerative disease of the macula that affects elderly people and cause central …
Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer
Ipilimumab (Yervoy, developed by Medarex and Bristol-Myers Squibb) is a fully human
monoclonal IgG1κ antibody against the cytotoxic T-lymphocyte antigen-4 (CTLA-4), an immune-…
monoclonal IgG1κ antibody against the cytotoxic T-lymphocyte antigen-4 (CTLA-4), an immune-…